Scipher Medicine has entered into a multi-disease area collaboration with Ionis Pharmaceuticals. The partnership will focus on the development of precision therapeutics in disease areas including cardiovascular and CNS. Scipher will use its Spectra platform and proprietary dataset of patient molecular data to identify novel targets for specific patient populations. Ionis can advance targets identified by Scipher and both companies will identify patient subgroups more likely to benefit from therapy, potentially decreasing time to drug approval through targeted clinical trials.